USPTO serial 79044870
DEXO
Reviewed by CopyMark Law Group
Reg. 3516670Status 404
- Filing date
- Status date
- Registration date
- Oct 14, 2008
- Examiner
- STOIDES, KATHERINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DEXO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
FR
Laboratoires Pharmaceutiques; DEXO SA
F-92213 SAINT CLOUD Cedex, FR
Other trademarks owned by Laboratoires Pharmaceutiques; DEXO SA
Laboratoires Pharmaceutiques; DEXO SA
F-92213 SAINT CLOUD Cedex, FR
Other trademarks owned by Laboratoires Pharmaceutiques; DEXO SA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
G. Mathew Lombard
G MATHEW LOMBARD LOMBARD & GELIEBTER LLP305 BROADWAYFL 7NEW YORK, NY 10007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vitamins; Dietary, nutritional and mineral supplements in tablet, capsule, liquid or injectable form and meal replacement bars and meal replacement drink mixes; Medicated mouth washes and mouth rinses; Pharmaceutical preparations for the treatment of dry mouth, allergies, sinus diseases and conditions, rhinitis, congestion, and post-nasal drip; Pharmaceutical preparations, namely, antihistamines and decongestants; Pharmaceutical preparations for the relief of throat and mouth soreness; Pharmaceutical preparations for the prevention and treatment of inflammation, Pain, Cardiovascular diseases, disorders and conditions, Skin diseases, disorders and conditions, Cancer, Endocrinological diseases, disorders and conditions, Viral and bacterial infections, Parasitic infections, Gynecological infections, Ophthalmologic diseases, disorders and conditions, Metabolic diseases, disorders and conditions, Neurological and central nervous system diseases, disorders and conditions, Respiratory diseases, disorders and conditions, Urological diseases, disorders and conditions, Psychiatric diseases, disorders and conditions, Urological diseases, disorders and conditions, Musculo-skeletal diseases, disorders and conditions, and Rheumatism; Pharmaceutical preparations for smoking cessation; Gel films for use in the manufacture of capsules for drug delivery; Pharmaceutical preparations, namely, drug delivery systems comprising polymer-based and gel-based oral tablets and capsules a wide variety of therapeutic agents; Cough suppressants; Anti-nauseants; Anti-emetics; Anti-diarrhoeals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATOIRES ETHYPHARM
- Other trademarks owned by Laboratoires Pharmaceutiques; DEXO SA
- Other trademarks owned by Laboratoires Pharmaceutiques; DEXO SA
- Other trademarks in Class 005
- Similar marks named DEXO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2020 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 24, 2020 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 17, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 16, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 16, 2016 | INPC | INVALIDATION PROCESSED | — |
| Jan 15, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 25, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 15, 2015 | C71T | CANCELLED SECTION 71 | — |
| Dec 29, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 16, 2014 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 4, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 10, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 23, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 13, 2009 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 28, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 28, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 14, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 14, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 29, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 24, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 21, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 18, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jun 18, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 9, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 9, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 6, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 21, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 21, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 20, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 9, 2007 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Nov 8, 2007 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |